ERT and Bioclinica Merge

READ MORE Your digital transformation partners

A BETTER WAY TO
MANAGE YOUR
CLINICAL DEVELOPMENT

LEARN MORE Meet goals and achieve higher quality data, reduced costs, and shortened study timelines with support from ERT. Meet goals and achieve higher quality data, reduced costs, and shortened study timelines with support from ERT.

A BETTER WAY TO
MANAGE YOUR
CLINICAL DEVELOPMENT

5.2M+

Patients Enrolled

230K

Sites Supported

600+

Drug Approvals

15K

Trials Managed

a better way to manage your trials

Meet clinical development goals and achieve higher quality data, reduced costs, and shortened study timelines with support from ERT.

Deliver Your Vaccine Trials. Faster.

ERT speeds up your vaccine clinical studies, capturing patient data quickly and accurately with its dedicated vaccines ePRO solution.



MINIMIZE RISK AND UNCERTAINTY

We deliver the flexibility and adaptability you need to overcome challenges for faster speed to market. Here’s how:

230k investigative sites supported
Every trial runs into unexpected challenges. With more than 15,000 trials under our belt, we’ve seen them before and have the expertise to put your trial back on course with our predictive analytics.
25 ready-to-launch analytics tools
We protect  your trial before there’s ever an issue, ensuring its success through near real-time access to study, program and enterprise-level performance.

NEWS & EVENTS

LATEST NEWS

ERT Survey Reveals Challenges and Innovations within CNS Clinical Trials

Results demonstrate adoption of virtual and wearable technologies to increase effectiveness of CNS studies PHILADELPHIA ...

How You Can Optimize Outcome Assessments in Central Nervous System Trials with Advanced Training

Traditional methods for the monitoring and assessment of patients with Central Nervous System (CNS) disorders ...


Using Cognitive Assessment to Improve Decision Making in Oncology Clinical Trials

Using Cognitive Assessment to Improve Decision Making in Oncology Clinical Trials March 10, 2021 at ...